AI assistant
GlaxoSmithKline PLC — Director's Dealing 2014
Oct 23, 2014
5262_dirs_2014-10-23_9d553311-47d5-4384-ae45-724a967c12af.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 1732V
GlaxoSmithKline PLC
23 October 2014
GlaxoSmithKline plc
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
In accordance with DTR 3.1.4R(1)(a) I give below details of changes in the interests of Sir Andrew Witty, a Director, in the Ordinary Shares of GlaxoSmithKline plc (the "Company"):
The exercise of options over 77,500 Ordinary Shares on 23 October 2014, granted on 2 December 2004 under the GlaxoSmithKline Share Option Plan at a price of £11.23 per share, and the sale of 71,296 Ordinary Shares at a price of £13.84 per share on 23 October 2014.
The Company was advised of the transaction on 23 October 2014.
V A Whyte
Company Secretary
23 October 2014
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSQXLFLZBFLFBX